USFDA gives approval for generic acne-treating drug

The tablet is used for treatment of moderate to severe acne in people aged 12 years and above.

155
USFDA Approval
USFDA Approval

Last Updated on October 2, 2024 by The Health Master

New Delhi: Zydus Lifesciences said it has received final approval from the US health regulator for its generic antibiotic Minocycline Hydrochloride extended-release tablets used for treatment of moderate to severe acne.

The approval granted by the US Food and Drug Administration (USFDA) is for Minocycline Hydrochloride extended-release tablets of strengths 55 mg, 65 mg, and 115 mg, Zydus Lifesciences said in a regulatory filing.

The tablet is used for treatment of moderate to severe acne in people aged 12 years and above.

The product will be manufactured at the group’s formulation manufacturing facility in Moraiya, Ahmedabad, the company said.

USFDA gives final nod for Varenicline Tablets

USFDA gives approval for Levetiracetam Tablets

USFDA gives approval for Metoprolol Succinate ER Tablets

USFDA gives approval for Cisatracurium Besylate injection

USFDA gives nod for Esomeprazole Magnesium Suspension

USFDA gives approval for Nitisinone capsules

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news